Genetic susceptibility to multiple endocrine neoplasia [MEN]
ICD-10 Z15.81 is a billable code used to indicate a diagnosis of genetic susceptibility to multiple endocrine neoplasia [men].
Z15.81 indicates a genetic predisposition to multiple endocrine neoplasia (MEN), a group of disorders characterized by the development of tumors in multiple endocrine glands. This code is crucial for identifying patients who may require enhanced surveillance and preventive measures due to their genetic background. Social determinants of health, such as access to genetic counseling and screening services, significantly influence health outcomes for these patients. Preventive care strategies may include regular screenings for associated tumors, lifestyle modifications, and education about the implications of genetic susceptibility. The use of this code can facilitate appropriate referrals to specialists and ensure that patients receive comprehensive care tailored to their genetic risks.
Document family history, genetic testing results, and preventive care plans.
Routine checkups for patients with known genetic susceptibility, discussions about lifestyle modifications, and referrals for screenings.
Consider social determinants such as access to care, patient education, and support systems.
Collect data on population-level genetic predisposition and outcomes, track screening rates.
Epidemiological studies on MEN prevalence, community education programs about genetic risks.
Focus on health equity and access to genetic counseling and preventive services.
Used when a patient is being evaluated for MEN.
Document the reason for testing and results.
Primary care providers should coordinate with genetic specialists.
Z15.81 should be used when a patient has a confirmed genetic susceptibility to MEN, particularly when planning preventive care and screenings.
